DiviDrip · QNCX

QNCX — Quince Therapeutics, Inc.

QNCX is Quince Therapeutics, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $32.81. Market cap: $33M. Capital Quality Rank: 15/100 — Capital destroyer.

Stock snapshot

Price$32.81
Market cap$33M
SectorHealthcare
ExchangeNMS
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)15 / 100 · Capital destroyer
Shareholder buyback yield-13.64%
Altman Z-score zoneDistress

About QNCX

Quince Therapeutics Inc is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. Its proprietary AIDE technology is an inventive drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells. Its Phase 3 asset, eDSP, leverages the AIDE technology to encapsulate DSP into a patient's own red blood cells, and is targeted to treat a rare pediatric neurodegenerative disease, A-T.

Listed2019Employees38HQSouth San Francisco, CASectorHealthcareWebsitequincetx.com

Related non-dividend companies

Other non-dividend stocks investors research alongside QNCX. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is QNCX's current stock price?

QNCX (Quince Therapeutics, Inc.) is currently trading at $32.81.

Does QNCX pay a dividend?

QNCX (Quince Therapeutics, Inc.) does not currently pay a regular dividend.

What is QNCX's Capital Quality Rank?

QNCX has a Capital Quality Rank of 15/100 — Capital destroyer. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track QNCX in DiviDrip

Add QNCX to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-02. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow